Ignite Creation Date:
2025-12-24 @ 10:31 PM
Ignite Modification Date:
2025-12-28 @ 8:07 AM
Study NCT ID:
NCT01601535
Status:
COMPLETED
Last Update Posted:
2019-07-31
First Post:
2012-05-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of MLN8237 in Combination With Irinotecan and Temozolomide
Sponsor:
New Approaches to Neuroblastoma Therapy Consortium
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
N2009-03
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None